Recent studies identified that MeCP2 interacts with alternative splicing components, (e.g., Y-box binding protein 1 [YB-1]), and regulates their expression to influence alternative splicing events in neuroblastoma [25] or cancer cell lines [26]. The gene discussed is YBX1; the disease is cancer.